Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP422612.RAXMEkqgMWELcVcRIyJ3uO91_23EZHj64EjX9y2yanDEQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP422612.RAXMEkqgMWELcVcRIyJ3uO91_23EZHj64EjX9y2yanDEQ130_assertion type Assertion NP422612.RAXMEkqgMWELcVcRIyJ3uO91_23EZHj64EjX9y2yanDEQ130_head.
- NP422612.RAXMEkqgMWELcVcRIyJ3uO91_23EZHj64EjX9y2yanDEQ130_assertion description "[Inactivating mutations of the RET proto-oncogene and of one of its soluble ligand molecules, glial cell line derived neurotrophic factor (GDNF), have been found in a subset of patients with Hirschsprung disease (HSCR).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP422612.RAXMEkqgMWELcVcRIyJ3uO91_23EZHj64EjX9y2yanDEQ130_provenance.
- NP422612.RAXMEkqgMWELcVcRIyJ3uO91_23EZHj64EjX9y2yanDEQ130_assertion evidence source_evidence_literature NP422612.RAXMEkqgMWELcVcRIyJ3uO91_23EZHj64EjX9y2yanDEQ130_provenance.
- NP422612.RAXMEkqgMWELcVcRIyJ3uO91_23EZHj64EjX9y2yanDEQ130_assertion SIO_000772 10204848 NP422612.RAXMEkqgMWELcVcRIyJ3uO91_23EZHj64EjX9y2yanDEQ130_provenance.
- NP422612.RAXMEkqgMWELcVcRIyJ3uO91_23EZHj64EjX9y2yanDEQ130_assertion wasDerivedFrom befree-20150227 NP422612.RAXMEkqgMWELcVcRIyJ3uO91_23EZHj64EjX9y2yanDEQ130_provenance.
- NP422612.RAXMEkqgMWELcVcRIyJ3uO91_23EZHj64EjX9y2yanDEQ130_assertion wasGeneratedBy ECO_0000203 NP422612.RAXMEkqgMWELcVcRIyJ3uO91_23EZHj64EjX9y2yanDEQ130_provenance.